Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06342492 · ClinicalTrials.gov registry record

Conduction System Vs Surgical Left Ventricular Epicardial Pacing For Coronary Sinus Lead Failure

A clinical trial of Heart Failure With Reduced Ejection Fraction, sponsored by Kansas City Heart Rhythm Research Foundation.

Recruiting
Registry status
100
Enrollment target
1
Study location

NCT06342492 is a study of Heart Failure With Reduced Ejection Fraction that is actively recruiting participants, run by Kansas City Heart Rhythm Research Foundation. The registered enrollment target is 100 participants, below the 3,962-participant average among 27 other Heart Failure With Reduced Ejection Fraction trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06342492, a study of Heart Failure With Reduced Ejection Fraction, is actively recruiting participants, sponsored by Kansas City Heart Rhythm Research Foundation.

RECRUITING
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

This a single-center, retrospective, observational study of patients that undergo coronary sinus(CS) lead revision, comparing epicardial lead placement to coronary sinus pacing(CSP) in those that had lead failure.

Interventions

  • OTHER Coronary Sinus Lead Revision

Study Locations (1)

Kansas

  • Kansas City Heart Rhythm Institute - Overland Park

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2023-11-07
Est. Completion 2024-12

What the Registry Record Tells You About NCT06342492

The ClinicalTrials.gov registry entry for NCT06342492 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,962-participant average among 27 other Heart Failure With Reduced Ejection Fraction trials with a reported enrollment target (97% lower). The listed sponsor is Kansas City Heart Rhythm Research Foundation, which has 22 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Heart Failure With Reduced Ejection Fraction appearing as the primary indexed condition, and to 1 intervention - of which Coronary Sinus Lead Revision is the first listed.

NCT06342492 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.

Frequently Asked Questions

What is clinical trial NCT06342492 about?

NCT06342492 is a clinical study titled "Conduction System Vs Surgical Left Ventricular Epicardial Pacing For Coronary Sinus Lead Failure". This a single-center, retrospective, observational study of patients that undergo coronary sinus(CS) lead revision, comparing epicardial lead placement to coronary sinus pacing(CSP) in those that had lead failure.

What is the current status of trial NCT06342492?

This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2023-11-07. Estimated completion is 2024-12.

What conditions does trial NCT06342492 study?

This clinical trial studies the following conditions: Heart Failure With Reduced Ejection Fraction.

What interventions are being tested in trial NCT06342492?

The interventions under investigation include: Coronary Sinus Lead Revision (OTHER).

Who is sponsoring clinical trial NCT06342492?

This trial is sponsored by Kansas City Heart Rhythm Research Foundation, which has 22 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06342492 being conducted?

This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure With Reduced Ejection Fraction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.